Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitors

The ex vivo sensitivity of pediatric leukemia cells to the proteasome inhibitor bortezomib was compared to 3 next generation proteasome inhibitors: the epoxyketone-based irreversible proteasome inhibitors carfilzomib, its orally bio-available analog ONX 0912, and the immunoproteasome inhibitor ONX 0...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Niewerth, Denise, Franke, Niels E., Jansen, Gerrit, Assaraf, Yehuda G., van Meerloo, Johan, Kirk, Christopher J., Degenhardt, Jeremiah, Anderl, Janet, Schimmer, Aaron D., Zweegman, Sonja, de Haas, Valerie, Horton, Terzah M., Kaspers, Gertjan J.L., Cloos, Jacqueline
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2013
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3856965/
https://ncbi.nlm.nih.gov/pubmed/24056819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.092411
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados